Simponi Injectible Pens Recalled

RA Guy Community News

Some injection devices for this biologic medicine are found defective, but many, maybe all, have not yet reached consumers.

2/22/11 Nearly 900 injectable pens containing the biologic drug Simponi are being recalled in the U.S. because a defect in the delivery device may prevent the administration of a full dose of the medication – a TNF-alpha inhibitor approved to treat rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Read More: